Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Deborah Collyar: What's In It for Patients?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Advertisement

Advertisement




Jan
25
Today In Oncology
Addition of Cyclophosphamide to Posttransplantation GVHD Prophylaxis
Advanced NSCLC With Brain Metastases Potential Novel Therapeutic Option
Addition of Lenvatinib/Pembrolizumab to TACE in Unresectable Nonmetastatic HCC
New Study Highlights Financial Burden of Medical Equipment on Cancer Survivors
Muscular Strength Cardiorespiratory Fitness May Be Linked to Lower Risk of Mortality in Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo